SGLT2 inhibitors and cardiovascular outcomes in heart failure with mildly reduced and preserved ejection fraction: A systematic review and meta-analysis.

Banerjee M, Pal R, Nair K, Mukhopadhyay S

Open source

DOI
10.1016/j.ihj.2023.03.003
Published
2023 Mar-Apr
Container
Indian heart journal
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ihj.2023.03.003,
  title = {SGLT2 inhibitors and cardiovascular outcomes in heart failure with mildly reduced and preserved ejection fraction: A systematic review and meta-analysis.},
  author = {Banerjee M and Pal R and Nair K and Mukhopadhyay S},
  year = {2023},
  journal = {Indian heart journal},
  doi = {10.1016/j.ihj.2023.03.003},
  url = {https://doi.org/10.1016/j.ihj.2023.03.003}
}

RIS

TY  - JOUR
TI  - SGLT2 inhibitors and cardiovascular outcomes in heart failure with mildly reduced and preserved ejection fraction: A systematic review and meta-analysis.
AU  - Banerjee M
AU  - Pal R
AU  - Nair K
AU  - Mukhopadhyay S
PY  - 2023
JO  - Indian heart journal
DO  - 10.1016/j.ihj.2023.03.003
UR  - https://doi.org/10.1016/j.ihj.2023.03.003
ER  - 

APA

M, B., R, P., K, N., & S, M. (2023). SGLT2 inhibitors and cardiovascular outcomes in heart failure with mildly reduced and preserved ejection fraction: A systematic review and meta-analysis.. Indian heart journal. https://doi.org/10.1016/j.ihj.2023.03.003

Source records